Impilo, Amalungiselelo
Izidakamizwa ngempumelelo yokulwa ukuluthwa utshwala "Teturam": imiyalelo, Izimo
Ukuphuza ngokweqile akusona isifo ukuthi kube nzima ukwelapha ngokuphelele eyaziwa cishe kungenakwenzeka. Abanye abantu baye ichithe iminyaka emithathu izama ukuqeda lokhu kwencika, kodwa ngokuvamile umphumela uba zero. Namuhla, ngisho nasezimweni esingenathemba kakhulu, imizamo eyenziwe ku basekelwe ukuze iziguli usebenzisa izidakamizwa "Teturam" impatho okwakubekelwa kubhekwe olukhulu.
Ngakho, ekwakhiweni ezithaka imithi ngempumelelo ekwelapheni ukuluthwa utshwala. Ingqikithi asebenzayo we nomuthi - disulfiram - kuthinta enzyme ethize ehilelekile umzimba ethanol, okuholela ekwandeni lokuhlushwa esuselwe izidakamizwa. Ngenxa yalokho - ukunciphisa umfutho wabo wegazi, isicanucanu nokuhlanza, ukuquleka, tachycardia. Lezi zenzo ezimbi zikwenza ukusebenzisa utshwala futhi zibangele ukuya kuso. Umzimba usabela ngendlela efanayo ngisho kwafakwa isilinganiso esincane semithi ngotshwala eyenziwa ngesikhatsi ukwelashwa nale izidakamizwa.
Nomuthi "Teturam": Yokusetshenziswa umthamo
Utshwala kuyinkomba enkulu "Teturam" ukulungiselela. Yokwamukela izidakamizwa ngaphakathi kuvimbela ukuthuthukiswa lokubuya kwesifo ekwelapheni amafomu njalo utshwala. Imithi esetshenziswa kwezokwelapha njenge-ejenti ngokukhishwa kobuthi egazini ukuze nickel ubuthi.
Isikimu yokwelashwa, kanye umthamo wakhe nsuku zonke kunqunywa udokotela umuntu ngamunye. Kukhona isu elikhethekile kwezokuphatha (yenzeka) ku ongama izicubu okunamafutha umthamo othize (esiphezulu 800 mg) kwezidakamizwa "Teturam".
Imiyalelo singadluli Kunconywa umthamo zonke izinsuku we-500 mg lapho zaphathwa izidakamizwa.
Kuyaphawuleka ukuthi ngokwako umuthi izidakamizwa ayinangozi. On the nemisebenzi izinhlelo kanye nezinhlaka isiguli, ejenti ezithaka imithi "Teturam" akuphazamisi psyche, isimo jikelele isiguli akahlupheki. I asebenzayo izidakamizwa imithi iyaphendula kuphela utshwala. Kufanele kuphela ukuthatha utshwala nesineke njengoba nakanjani oza okubizwa ngokuthi "teturamovaya" ukuphendula.
Ezinye izihlobo abanezinhloso ezinhle kakhulu uncamela isiguli ngaphandle kolwazi lwakhe ukunikeza imithi "Teturam" umthamo ebulalayo izidakamizwa ngaleyo ndlela kungaba ukudlala ihlaya elibi ogulayo. Zokwelapha, zikhona kakade ezimweni lapho engalawuliwe kokuthola izidakamizwa ebulalayo esigulini. Ngakho-ke, ukwelapha izidakamizwa ngaphandle kwemvume lesiguli akuvunyelwe contraindicated. Ngaphambi kokuba uqale ukuthatha izidakamizwa kufanele kudokotela.
Izidakamizwa "Teturam": ukweqisa izidakamizwa, Izimo
Kukhona ingozi imiphumela emibi ukuthatha ngemithamo ngokweqile "Teturam". Umhlahlandlela uxwayisa ngengozi inhlanganisela ethanol futhi teturam. ngobudedengu okunjalo kungaholela ukucindezelwa ukwazi ngisho equlekile. Ngokuvamile kukhona nciphisa zenhliziyo, kungenzeka yezinkinga zezinzwa.
Indlelanchubo eliyelelweko umthamo izidakamizwa uyakwazi ukuvikela kusuka kule ingozi. Ukwelashwa ngokweqile imithi inikezwa lingaze.
Ngokuzimisela kufanele ayiswe contraindications lesi sidakamizwa "Teturam". Umhlahlandlela uxwayisa kungenzeka imiphumela emibi kulezi zimo ezilandelayo:
- isiguli kucikelela ethile zomuthi;
- isiguli isifo senhliziyo;
- yamaphaphu sofuba (isinyathelo lapho isiguli hemoptysis);
- isifuba somoya bronchial, isilonda peptic, ukwehluleka kwezinso nesibindi, izifo ezithathelwanayo we sezinzwa uhlelo, isifo sikashukela kanye nesifo sokuwa;
- phezu ukuthola izimila ebulalayo, ukufiphala kwamehlo neuritis sokuzwa noma emsipheni optic;
- Ukukhulelwa, lactation.
Izinkinga kanye nemiphumela engemihle zomuthi zingahlukaniswa zibe 3 subgroups.
I iqeqebana lokuqala lihlanganisa imiphumela ezibangwa izakhiwo asebenzayo izidakamizwa disulfiram.
Eyesibili iqeqebana - imithelela emibi inhlanganisela utshwala-teturam.
Esesithathu iqeqebana - yezinkinga okudalwe ukusebenzisa isikhathi eside ngokweqile zomuthi.
Khipha uhlobo umuthi i-tablet. izimo Storage - amnyama, epholile, endaweni engafinyeleleki ezinganeni. Ayikwazi ukusetshenziselwa ngemva kosuku kuboniswe kwi isembozo izidakamizwa.
Similar articles
Trending Now